Project Details
| Status | Active |
|---|---|
| Effective start/end date | 1/24/23 → 1/23/28 |
Funding
- Pfizer, Inc.: $14,202.00
Protocol No. C5261001: A Phase 1 Randomized Study to Evaluate the Safety, Tolerability, and Immunogenicity of Combined Modified RNA Vaccine Candidates Against COVID-19 and Influenza in Healthy Individuals
- Rupp, Richard (PI)
Project: Research project